This low-level labelling of dystrophin is absent only in patients with DMD in whom the MANDYS106 epitope (coded in exon 43) is deleted (data not shown), implying that a genuine product of DMD is detected by this high-affinity antibody. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.